NEW YORK (GenomeWeb News) – GeneLink today reported that its third-quarter revenues increased nearly 17 percent to $2.1 million from $1.8 million for the third quarter of 2008, with nearly all of its sales coming from its GeneWize nutritional and dermatological genetic testing services.

GeneLink posted a net loss of $784,000 for the quarter ended Sept. 30, an increase of 53 percent over its net loss of $514,000 for third quarter of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.